ENGN
Price
$4.87
Change
+$0.07 (+1.46%)
Updated
Sep 3 closing price
Capitalization
253.48M
LRMR
Price
$3.94
Change
+$0.23 (+6.20%)
Updated
Sep 3 closing price
Capitalization
337.65M
75 days until earnings call
Interact to see
Advertisement

ENGN vs LRMR

Header iconENGN vs LRMR Comparison
Open Charts ENGN vs LRMRBanner chart's image
enGene Holdings
Price$4.87
Change+$0.07 (+1.46%)
Volume$226.01K
Capitalization253.48M
Larimar Therapeutics
Price$3.94
Change+$0.23 (+6.20%)
Volume$1.51M
Capitalization337.65M
ENGN vs LRMR Comparison Chart in %
Loading...
ENGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ENGN vs. LRMR commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENGN is a Buy and LRMR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (ENGN: $4.80 vs. LRMR: $3.71)
Brand notoriety: ENGN and LRMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENGN: 116% vs. LRMR: 132%
Market capitalization -- ENGN: $253.48M vs. LRMR: $337.65M
ENGN [@Biotechnology] is valued at $253.48M. LRMR’s [@Biotechnology] market capitalization is $337.65M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENGN’s FA Score shows that 1 FA rating(s) are green whileLRMR’s FA Score has 1 green FA rating(s).

  • ENGN’s FA Score: 1 green, 4 red.
  • LRMR’s FA Score: 1 green, 4 red.
According to our system of comparison, both ENGN and LRMR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENGN’s TA Score shows that 5 TA indicator(s) are bullish while LRMR’s TA Score has 4 bullish TA indicator(s).

  • ENGN’s TA Score: 5 bullish, 4 bearish.
  • LRMR’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ENGN is a better buy in the short-term than LRMR.

Price Growth

ENGN (@Biotechnology) experienced а +10.09% price change this week, while LRMR (@Biotechnology) price change was -4.13% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +16.10%, and the average quarterly price growth was +32.67%.

Reported Earning Dates

LRMR is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LRMR($338M) has a higher market cap than ENGN($253M). LRMR YTD gains are higher at: -4.134 vs. ENGN (-27.820). ENGN has higher annual earnings (EBITDA): -76.26M vs. LRMR (-108.21M). ENGN has more cash in the bank: 217M vs. LRMR (139M). LRMR has less debt than ENGN: LRMR (4.61M) vs ENGN (25.4M). ENGN (0) and LRMR (0) have equivalent revenues.
ENGNLRMRENGN / LRMR
Capitalization253M338M75%
EBITDA-76.26M-108.21M70%
Gain YTD-27.820-4.134673%
P/E RatioN/AN/A-
Revenue00-
Total Cash217M139M156%
Total Debt25.4M4.61M550%
FUNDAMENTALS RATINGS
LRMR: Fundamental Ratings
LRMR
OUTLOOK RATING
1..100
79
VALUATION
overvalued / fair valued / undervalued
1..100
29
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ENGNLRMR
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 13 days ago
87%
Bullish Trend 7 days ago
86%
Declines
ODDS (%)
Bearish Trend 21 days ago
90%
Bearish Trend 16 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
ENGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HYDTF2.380.04
+1.79%
Hydreight Technologies Inc
HLTOY9.35N/A
N/A
Hellenic Telecommunications Organization S.A.
PLFRF43.80N/A
N/A
Palfinger AG
ATLPF16.24-0.13
-0.77%
Atlas Copco AB
MSMGF0.06N/A
-6.83%
Grid Metals Corp.

ENGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENGN has been closely correlated with TNFA. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if ENGN jumps, then TNFA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENGN
1D Price
Change %
ENGN100%
+3.90%
TNFA - ENGN
68%
Closely correlated
-21.33%
COGT - ENGN
48%
Loosely correlated
-0.66%
LRMR - ENGN
30%
Poorly correlated
+2.49%
TELO - ENGN
29%
Poorly correlated
-9.09%
ATHE - ENGN
29%
Poorly correlated
+4.45%
More

LRMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, LRMR has been loosely correlated with SYRE. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if LRMR jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LRMR
1D Price
Change %
LRMR100%
+2.49%
SYRE - LRMR
48%
Loosely correlated
+0.85%
OCUL - LRMR
48%
Loosely correlated
+4.01%
EYPT - LRMR
48%
Loosely correlated
+1.38%
ERAS - LRMR
47%
Loosely correlated
+1.91%
ACLX - LRMR
47%
Loosely correlated
+0.52%
More